Is Amycretin legal in the US?
Not yet; it is still in trials.
BSome human evidenceIn clinical trialsas of 2026-10-26
Amycretin (international nonproprietary name zenagamtide) is an investigational drug from Novo Nordisk and is not approved by the FDA or any other regulator. It entered phase 3 trials for weight management in 2026. 14
No. It is in phase 3 trials and has not been submitted for approval anywhere. Any product sold online under this name is unregulated. 14
More on Amycretin
Citations
- Mora 2026, Lancet: oral zenagamtide (amycretin) phase 2 trial in type 2 diabetes doi.org
- StatPearls: Glucagon-like peptide-1 receptor agonists ncbi.nlm.nih.gov
- Lancet 2025: subcutaneous amycretin phase 1b/2a randomised controlled study doi.org
- ClinicalTrials.gov: AMAZE 1 phase 3 trial of amycretin clinicaltrials.gov
- Gasiorek 2025, Lancet: first-in-human phase 1 trial of oral amycretin doi.org
Reference information only, not medical advice. Drawn from the Amycretin article, fact-checked against the cited sources. No dosing anywhere on this site.